Announcements

Two New Students Join The Cato T. Laurencin Institute of Regenerative Engineering Master of Science in Regenerative Engineering Program

The Cato T. Laurencin Institute is delighted to introduce Robert Bunis and Gina Airoldi as our first MSc in Regenerative Engineering cohort. Their academic excellence and well-aligned applications marked them as outstanding candidates. The Master of Science in Regenerative Engineering program is intended to train a new transdisciplinary workforce for Regenerative Engineering. Regenerative Engineering is a new field defined as the convergence of advanced materials science, stem cell science, physics, developmental biology, and clinical translation for the regeneration of complex tissues and organ systems. The coursework and research projects of the program allow students to delve into the latest advancements, technologies, and challenges in this rapidly growing field.

Robert Bunis is a UConn alumnus with a degree in Biomedical Engineering and graduated Magna Cum Laude. Robert is passionate about the field. He states, “I would say that I joined the regenerative engineering program because of the ever-growing potential that regenerative engineering has. I have always been very interested in science and medicine and see a promising future regarding the use of stem cells and improving upon current medical technologies. I hope to make a positive impact on the medical community and research advancements that will help improve the lives of others.”

Gina Airoldi graduated from the University of Vermont with a Bachelor of Science in Biomedical Engineering. Gina is also a part of the institute’s Young Innovative Investigator Program. Gina states, “It allows me to specialize my more broad “Biomedical Engineering” undergraduate degree. Being able to collaborate with UConn Health in Farmington and UConn in Storrs provides opportunities to learn from and work with experts in a variety of fields, allowing me to hone my medical and health interests while still utilizing engineering fundamentals. The research being done in Regenerative Engineering here at UConn and UConn Health is innovative and inspiring, and I truly believe this field will create new possibilities for medicine and saving lives.”

The primary inspiration behind such a program stem from the pressing need to develop novel solutions for diseases and injuries that currently have limited treatments. Whether it is a spinal cord injury, bone fractures, organ failure, or degenerative diseases, Regenerative Engineering offers hope for potentially groundbreaking treatments. The M.S. program is designed to equip the next generation of scientists and engineers with the necessary skills and knowledge to push the boundaries of what’s possible in regenerative medicine.

“I am excited to have these two impressive students be part of the institute”, said Dr. Cato Laurencin, CEO of The Cato T. Laurencin Institute for Regenerative Engineering at UConn.

Dr. Laurencin applauds three Regenerative Engineering Scientists honored by The Biomedical Engineering Society

In the month of October, three scientists in the field of regenerative engineering will be receiving awards from the Biomedical Engineering Society (BMES). The winners are, Guillermo Ameer, Tejal Desai, and Jian Yang. Each winner will give a lecture at the 2023 BMES Annual Meeting in Seattle.

“I congratulate these three outstanding engineer/scientists who have made extraordinary contributions to Regenerative Engineering. It is wonderful to see their efforts recognized by the Biomedical Engineering Society and the biomedical community in general.,” said Dr. Cato Laurencin, CEO of The Cato T. Laurencin Institute for Regenerative Engineering at UConn, and Founder of the Regenerative Engineering Society.

Dr. Guillermo Ameer is the Director of the Center for Advanced Regenerative Engineering (CARE) at Northwestern University where he is the Daniel Hale Williams professor of Biomedical Engineering and Surgery at Northwestern University. He will be receiving the BMES Athanasiou Medal of Excellence in Translational Bioengineering Award (the Athanasiou Medal). This award recognizes achievements of an individual who has made outstanding contributions to the field of biomedical engineering with particular focus on translation.

Dr. Tejal Desai is the Sorensen Family Dean of Engineering Brown University. She will be receiving the Robert A. Pritzker Distinguished Lecture Award. This is the highest honor of the American Chemical Society. She is an accomplished biomedical engineer and academic leader who co-organized a Regenerative Engineering Society Rockstars Meeting.

Dr. Jian Yang is a Chair Professor in Biomaterials and Regenerative Engineering, and the chair of Biomedical Engineering Program at the Westlake University. He will be receiving the Wallace H. Coulter Award for Healthcare Innovation Award. This award recognizes achievements of an individual who is integrally involved in the development of a biomedical device, diagnostic test/device, or combination device drug/device in industry.

 

Best Materials Science Scientists

The 1st edition of Research.com ranking of the best scientists in the arena of materials science is based on data consolidated from various data sources, including data sources including OpenAlex and CrossRef. The bibliometric data for estimating the citation-based metrics were gathered on December 6th, 2021.

Position in the ranking is based on a scientist’s D- index (Discipline H- index), which only includes papers and citation values for an examined discipline.

 

Dr. Cato T. Laurencin Meets Pope Francis

Professor Cato T Laurencin was invited to the Vatican to meet with Pope Francis and to discuss his work on Regenerative Engineering. During the visit. Dr. Laurencin gave Pope Francis an honorary Cato T. Laurencin Regenerative Engineering Founder’s Award Medal.

This medal, endowed by the Regenerative Engineering Society and the American Institute of Chemical Engineers Foundation, recognizes leadership in the science and practice of convergence research as applied to regeneration.

Dr. Laurencin has made seminal contributions to tissue regeneration, biomaterials science, and nanotechnology. He founded the field of regenerative engineering and has been considered to be the foremost engineer-physician-scientist in the world. His groundbreaking achievements have led to important advances in improving human life. He is the first surgeon to be elected to the National Academy of Sciences, the National Academy of Engineering, the National Academy of Medicine and the National Academy of Inventors. During his visit to the Vatican, Dr. Laurencin provided an important lecture on the field of Regenerative Engineering. He discussed the Hartford Engineering a Limb project aimed at addressing the grand challenge of whole limb regeneration. Laurencin is the University Professor and Albert and Wilda Van Dusen Distinguished Endowed Professor of Orthopaedic Surgery at the University of Connecticut.

The Cato T. Laurencin Institute Launched at UConn

Dr. Cato Laurencin
A celebratory reception for the new Laurencin Institute was held on February 24 at UConn School of Medicine in Farmington.

We are excited to announce a new institute. It is entitled The Cato T. Laurencin Institute for Regenerative Engineering. “This initiative is only one of the countless number of Dr. Laurencin’s contributions to the development of science and engineering”, says Provost Anne D’Alleva.

Regenerative engineering is a field founded by Professor Cato T. Laurencin. It is described as the convergence of advanced materials sciences, stems cell science, physics, developmental biology, and clinical translation for the regeneration of complex tissues and organ systems. The Cato T. Laurencin Institute for Regenerative Engineering represents a transdisciplinary effort at UConn with a focus on the musculoskeletal area. The Institute integrates medicine, engineering, surgery, biology, physics, chemistry, and statistics/machine learning to enable a powerful platform for addressing scientific and medical problems in the regeneration and healing of complex tissues, organs, or organ systems.

The Cato T. Laurencin Institute of Regenerative Engineering holds to the pillars developed for the first Cato T. Laurencin Institute, namely:

Excellence in Science

Anti-Racism and Justice

Sponsorship and Mentorship

International, National, and Community Action

Transformative Technologies for Humanity

Economic Value Creation

In addition to this endeavor, Dr. Laurencin has created a ground-breaking project. It is entitled, Cato T. Laurencin Innovative Convergence Ventures (CTLICV). The CTLICV invests in next-generation companies based on innovative research conducted created within the Institute and its collaborating partners across UConn and greater university and corporate communities. We seek strong co-investor syndicates to develop products across a range of categories including regenerative engineering, drugs, devices, diagnostics, and digital health. The intent is to fast-track innovative research from bench to bed, with measurable impact on public health, quality of life, reducing societal disparity, and economic development.

CTLICV’s investments are directed at the seed and Series A stages, where it attracts capital and talent into the most difficult-to-fund phase of company development. When we invest, we expect to support each portfolio company through its entire financing lifecycle. We leverage the portfolio investment activity and internal/external relationships to further the mission vision and values of the Institute. Additionally, the fund taps into our experience in starting and growing companies, our expertise in the medical industry, and our network of scientific and business talent to build great companies.

The scientific and educational opportunities being pursued now and in the future at UConn will enable innovation and problem-solving beyond conventional academic boundaries. A core mission of UConn is precisely to foster new ways of thinking and new approaches to answers in medicine, science, engineering, and technology. We invite you to engage with us as we continue our work here at UConn.

The Cato T. Laurencin Institute for Regenerative Engineering
New Institute Logo

Dr. Cato T. Laurencin receives the Founders’ Award

The American Institute of Chemical Engineers Foundation (AIChE) and the AIChE Regenerative Engineering Society has established an award in honor of the society’s founder. The Cato T. Laurencin, Regenerative Engineering Founders’ Award, will recognize the accomplishments of individuals who have demonstrated leadership in the science and practice of convergence research as applied to regenerative engineering — a field pioneered by Dr. Cato T. Laurencin, the RE Society’s Founder. He received the American Institute of Chemical Engineers’ Founder’s Award this year at the AICHE annual meeting on November 14. The inaugural award will be presented in 2023 at the Regenerative Engineering Society’s Annual Meeting.

The award consists of a struck medal and an honorarium.

Laurencin, who is internationally renowned for his work in biomaterials, stem cell science, nanotechnology, drug delivery systems, as well the new field of regenerative engineering, serves as the chief executive officer of the Connecticut Convergence Institute for Translation in Regenerative Engineering Laurencin is the first surgeon in history to be elected to all four national academies: the National Academy of Sciences, the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors. He is the first person in history to receive the oldest/highest award of the National Academy of Medicine (the Walsh McDermott Medal) and the oldest/highest award of the National Academy of Engineering (the Simon Ramo Founder’s Award). In science, he received the Philip Hauge Abelson Prize given “for signal contributions to the advancement of science in the United States.

The field of regenerative engineering involves the convergence of advanced materials sciences, stem cell science, physics, developmental biology, and clinical translation to regenerate complex tissues and organ systems. The Cato T. Laurencin Regenerative Engineering Society Founders’ Award will be presented to distinguished researchers, innovators, mentors, and teachers who have furthered the goals of this field. Nominations for the inaugural prize are due on April 15, 2023.

 

10-year Anniversary of Regenerative Engineering Celebration

On November 14, 2022, Dr. Cato Laurencin, the CEO of The Connecticut Convergence Institute and the Regenerative Engineering Society (RES), celebrated ten years of Regenerative Engineering.

Regenerative engineering combines advanced materials sciences, stem cell science, physics, developmental biology, and clinical translation to regenerate complex tissues and organ systems. Embedded in this new field include the following five areas: Advanced Materials Sciences, Stem Cell Sciences, Physics, Developmental Biology, and Clinical Translation.

When parts of organs are destroyed, it is difficult to completely repair or regenerate. Wounds undergo fibrosis because of intense inflammatory reactions, eventually settling down, hardening or scarring. This research field is interested in the study of the mechanisms underlying fibrosis in various organs and the research and development of fibrosis control technologies for therapeutic purposes. This type of breakthrough will tremendously impact public health and the lives of those with amputations due to bone cancer, diabetes, dangerous infections, trauma accidents, or even children born with missing or impaired limbs.

Dr. Cato Laurencin and the Connecticut Convergence Institute team have conducted many journals, studies, and articles. You can find the latest publications and journals on the website: health.uconn.edu/regenerative-engineering-institute.

 

 

Stephanie Chinwo, YIIP Scholar, received the 2022 American Society for Bone and Mineral Research Young Investigator Award

Stephanie Chinwo received the 2022 American Society for Bone and Mineral Research (ASBMR) Young Investigator Award for her abstract presentation Molecular Analysis of AMBRA1 as a Candidate Tumor Suppressor in Sporadic Parathyroid Adenomas. She accepted a commemorative plaque and honorarium during an ASMBR President’s Reception at the Annual Meeting held in September 2022 at Austin TX. ASBMR is a professional, scientific and medical society established to bring together clinical and experimental scientists who are involved in the study of bone and mineral metabolism.

 

Dr. Laurencin and the Connecticut Convergence Institute for Translation in Regenerative Engineering at the University of Connecticut Congratulate Masters in Clinical and Translational Science Graduate

 

The Connecticut Convergence Institute for Translation in Regenerative Engineering at the University of Connecticut is please to congratulate Courtney D. Townsel, MD, MSc who recently published an article entitled “More than grit: growing and sustaining physician-scientists in obstetrics and gynecology” in the American Journal of Obstetrics & Gynecology.

 

Dr. Townsel, a Maternal-Fetal Medicine specialist, completed her Masters in Clinical and Translational Research at the University of Connecticut’s Connecticut Convergence Institute. After graduating from the University in 2018, she accepted a faculty position at the University of Michigan. She has been very successful with her research areas which include health disparities and substance use disorder in pregnancy. The Connecticut Convergence Institute for Translation in Regenerative Engineering at the University of Connecticut is proud to have the opportunity to recognize Dr. Townsel and looks forward to her continued success.

 

To read more, view the newly published article here.

Connecticut Convergence Institute for Translation in Regenerative Engineering Fellow in Health Disparities Elimination and Community Action

Connecticut Convergence Institute for Translation in Regenerative Engineering

Fellow in Health Disparities Elimination and Community Action

Postdoctoral Fellow position in Health Disparities

Connecticut Convergence Institute for Translation in Regenerative Engineering at the University of Connecticut is seeks to hire a full time, Postdoctoral Research Fellow position in the CT Convergence Institute.

The Health Disparities Fellow will work closely with the Chief Executive Officer and Assistant Director of the Connecticut Convergence Institute on Health Disparities related initiatives and will contribute to research and community engagement initiatives associated with the Connecticut Convergence Institute Health Disparities Core Projects. In this capacity, the fellow will work on a new National Academies of Science, Engineering and Medicine Roundtable on Black Men and Black Women in Medicine, Engineering and Science.  The fellow will be engaged part time to work with the development of Perspective papers and surveys related to issues facing Black Men and Black Women in Medicine, Engineering and Science.  The Fellow will also work with members of the Roundtable on formulation of follow on projects from ideas generated from the Roundtable.  In addition, the Fellow will work on community health disparities projects funded by an Aetna Foundation Community Partnership Grant to the Connecticut Convergence Institute. The Fellow will also serve on the editorial board of the Journal of Racial and Ethnic Health Disparities, published by Springer Nature and having its home at the Connecticut Convergence Institute at UCONN.

The successful candidate must hold a terminal professional degree (e.g. Ph.D. M.D., and/or M.P.H.) and have demonstrated potential for success based on scholarly record and demonstrated interest in health disparities, and have the ability to work in collaboration with clinical, translational and/or basic scientists.

A curriculum vitae and a cover letter (in pdf files) and questions regarding this search should be directed to Dr. Lakshmi Nair, Associate Director of the Connecticut Convergence Institute at nair@uchc.edu.